Merus and Biohaven Strike New ADC Collaboration
Late Sunday, the Dutch oncology company Merus and Connecticut-based Biohaven announced a co-development and licensing partnership that will leverage each company’s respective tech. Under the terms of the deal, Merus will generate three antibodies—one of …